Chemical Properties
CAS |
35773-42-3 |
|
Formula |
C20H18N2O3 |
MW |
334.36852 |
Storage |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Biological activity
Description |
CAS NO.:35773-42-3
Product Name:2H-1-Benzopyran-2-one,3-(2-benzoxazolyl)-7-(diethylamino)-
Synonyms:
EINEC:
Molecular Formula:C20H18N2O3
Molecular Weight:334.36852 |
Target: |
EGFRdel19 T790M C797S
EGFRL858R/T790M/C797S |
In Vivo |
|
In Vitro |
EMI1 inhibits PC9 EGFR ex19del/T790M/C797S organoid growth with the EC50 of 131 nM[1]. EMI1 (1 nM-10 μM) potently reduces the interaction of EGFR triple mutant with Shc1[1]. EMI1 (1 nM-100μM) strongly inhibits the viability and increase the caspase 3/7 activity of PC9 EGFR ex19del/T790M/C797S triple-mutant cells than noncancerous human bronchial epithelial (HBE) cells[1]. Cell Viability Assay[1] Cell Line: PC9 EGFR ex19del/T790M/C797S and HBE bronchial epithelial lung EGFR-WT control cells. Concentration: 0.001, 0.01, 0.1, 1, 10, 100 μM Incubation Time: 72 hours Result: Strongly inhibited the viability. |
Kinase Assay |
|
Cell Assay |
|
Animal Administration |
|
References
[1]. Punit Saraon, et al. A drug discovery platform to identify compounds that inhibit EGFR triple mutants. Nat Chem Biol. 2020 May;16(5):577-586 |
|
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470
Email:
sales@dcchemicals.com
order@dcchemicals.com
Website:
www.dcchemicals.com
|